Patent · US Active

Gene signatures for cancer prognosis

US10876164B2 · kind B2 · utility

1Cited by

16References

4Claims

0Family size

Assignee

Myriad Genetics, Inc. · US

Inventors

Steven Stone · Salt Lake City, US
Alexander Gutin · Salt Lake City, US
Susanne Wagner · Mittenwalde, DE
Julia Reid · Salt Lake City, US

Key dates

Filing date	May 15, 2015
Grant date	Dec 29, 2020
Priority date	—
Expiry date	May 15, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.